Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for Boehringer Ingelheim
Explore 172 clinical trials worldwide
Search
Showing 1-50 of 172 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: Boehringer Ingelheim
Clinical Trials (172)
NCT07044700
Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction
N/A
Not yet recruiting
5,000 participants
Started: Jan 31, 2026 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT07047508
Real-world Study to Describe the Effectiveness and Safety Outcomes of Jardiance in Chinese Patients With Heart Failure and Preserved Ejection Fraction
N/A
Not yet recruiting
3,000 participants
Started: Jan 30, 2026 · Completed: Dec 31, 2028
2 conditions
1 sponsor
0 locations
NCT07201922
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
PHASE3
Not yet recruiting
80 participants
Started: Jan 23, 2026 · Completed: May 23, 2029
3 conditions
1 sponsor
44 locations
NCT07074418
Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2
PHASE4
Not yet recruiting
34 participants
Started: Dec 31, 2025 · Completed: Aug 31, 2027
1 condition
2 sponsors
1 location
NCT07195695
Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically Removed, Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
PHASE3
Not yet recruiting
400 participants
Started: Dec 5, 2025 · Completed: Sep 2, 2036
1 condition
1 sponsor
159 locations
NCT07220083
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
PHASE3
Not yet recruiting
286 participants
Started: Dec 5, 2025 · Completed: Mar 20, 2030
1 condition
1 sponsor
0 locations
NCT06886009
Spesolimab Post-marketing Surveillance in Korean Patients With Flares With Generalized Pustular Psoriasis
N/A
Not yet recruiting
21 participants
Started: Nov 28, 2025 · Completed: Jun 8, 2029
1 condition
1 sponsor
4 locations
NCT07107945
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
PHASE3
Not yet recruiting
120 participants
Started: Nov 7, 2025 · Completed: Jun 25, 2029
1 condition
1 sponsor
93 locations
NCT07215260
A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body
PHASE1
Not yet recruiting
14 participants
Started: Nov 4, 2025 · Completed: Dec 22, 2025
1 condition
1 sponsor
1 location
NCT07192991
Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America
N/A
Not yet recruiting
200 participants
Started: Nov 3, 2025 · Completed: Sep 30, 2026
2 conditions
4 sponsors
0 locations
NCT07036523
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment
PHASE2
Not yet recruiting
70 participants
Started: Oct 21, 2025 · Completed: Sep 2, 2027
1 condition
1 sponsor
48 locations
NCT07176975
A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers
PHASE1
Not yet recruiting
46 participants
Started: Oct 21, 2025 · Completed: May 30, 2029
1 condition
1 sponsor
1 location
NCT06241560
A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood
PHASE2
Not yet recruiting
20 participants
Started: Oct 20, 2025 · Completed: Feb 20, 2026
1 condition
1 sponsor
2 locations
NCT06906640
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
NA
Not yet recruiting
1,170 participants
Started: Oct 15, 2025 · Completed: Apr 1, 2027
3 conditions
4 sponsors
1 location
NCT06906627
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
NA
Not yet recruiting
800 participants
Started: Oct 10, 2025 · Completed: Apr 1, 2027
3 conditions
4 sponsors
6 locations
NCT07211425
A Study in Healthy People to Test How Itraconazole Influences the Amount of BI 3031185 in the Blood
PHASE1
Not yet recruiting
14 participants
Started: Oct 8, 2025 · Completed: Dec 18, 2025
1 condition
1 sponsor
1 location
NCT06806592
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
PHASE3
Recruiting
400 participants
Started: Sep 13, 2025 · Completed: Jul 30, 2027
2 conditions
1 sponsor
156 locations
NCT07133399
A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood
PHASE1
Active, not recruiting
32 participants
Started: Sep 8, 2025 · Completed: Oct 22, 2025
1 condition
1 sponsor
1 location
NCT06619405
AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance
NA
Recruiting
100 participants
Started: Aug 15, 2025 · Completed: Dec 31, 2027
1 condition
3 sponsors
1 location
NCT07001475
A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder
PHASE1
Recruiting
96 participants
Started: Aug 12, 2025 · Completed: May 27, 2026
2 conditions
1 sponsor
8 locations
NCT06957756
A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems
PHASE1
Recruiting
44 participants
Started: Aug 6, 2025 · Completed: Jun 29, 2026
1 condition
1 sponsor
3 locations
NCT07065617
A Study to Test How BI 1819479 is Taken up and Processed by the Body
PHASE1
Recruiting
14 participants
Started: Aug 4, 2025 · Completed: Apr 19, 2026
1 condition
1 sponsor
1 location
NCT06878365
A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 Interferonopathies
PHASE1
Recruiting
18 participants
Started: Jul 29, 2025 · Completed: Dec 7, 2026
1 condition
1 sponsor
18 locations
NCT07071974
A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body
PHASE1
Active, not recruiting
16 participants
Started: Jul 28, 2025 · Completed: Oct 14, 2025
1 condition
1 sponsor
1 location
NCT07063316
SGLT2 Inhibitors and Renal Anemia in Japan: RWD
N/A
Active, not recruiting
15,000 participants
Started: Jul 23, 2025 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT07064473
A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
PHASE3
Recruiting
11,800 participants
Started: Jul 22, 2025 · Completed: Dec 21, 2029
3 conditions
1 sponsor
1151 locations
NCT06926660
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
PHASE2
Recruiting
416 participants
Started: Jul 18, 2025 · Completed: Jan 8, 2027
1 condition
1 sponsor
162 locations
NCT07023354
A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems
PHASE1
Recruiting
32 participants
Started: Jul 17, 2025 · Completed: Mar 20, 2026
2 conditions
1 sponsor
3 locations
NCT06053164
Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease
PHASE2
Recruiting
60 participants
Started: Jul 1, 2025 · Completed: Sep 1, 2026
1 condition
2 sponsors
1 location
NCT06912659
The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib
N/A
Recruiting
493 participants
Started: Jun 23, 2025 · Completed: Dec 23, 2026
1 condition
1 sponsor
1 location
NCT05819385
Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) Epidemiology Non-interventional Study (NIS)
N/A
Recruiting
312 participants
Started: Jun 18, 2025 · Completed: Dec 1, 2027
1 condition
2 sponsors
1 location
NCT06872892
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
PHASE3
Recruiting
1,755 participants
Started: Jun 9, 2025 · Completed: Oct 12, 2028
1 condition
1 sponsor
513 locations
NCT06984926
A Study to Test How Well Multiple Doses of BI 3810477 Are Tolerated by Healthy Adults
PHASE1
Recruiting
48 participants
Started: Jun 6, 2025 · Completed: Mar 9, 2026
1 condition
1 sponsor
1 location
NCT06962839
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
PHASE2
Recruiting
300 participants
Started: Jun 5, 2025 · Completed: Sep 29, 2027
1 condition
1 sponsor
76 locations
NCT06955260
SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure
PHASE3
Not yet recruiting
410 participants
Started: May 31, 2025 · Completed: Mar 31, 2028
1 condition
3 sponsors
1 location
NCT06962852
A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI 3720931 (Lenticlair™-ON)
PHASE1/PHASE2
Recruiting
285 participants
Started: May 20, 2025 · Completed: Jul 17, 2048
1 condition
1 sponsor
10 locations
NCT06935370
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
PHASE3
Recruiting
4,200 participants
Started: May 20, 2025 · Completed: Feb 22, 2029
1 condition
1 sponsor
612 locations
NCT06806852
A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone
PHASE1
Recruiting
90 participants
Started: May 14, 2025 · Completed: Mar 30, 2028
1 condition
1 sponsor
59 locations
NCT06916702
A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men
PHASE1
Recruiting
60 participants
Started: Apr 7, 2025 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT06882746
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
PHASE1
Recruiting
135 participants
Started: Mar 28, 2025 · Completed: May 12, 2027
3 conditions
1 sponsor
3 locations
NCT06745284
A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity
PHASE1
Recruiting
60 participants
Started: Mar 26, 2025 · Completed: Jan 8, 2027
1 condition
1 sponsor
2 locations
NCT06624670
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
PHASE3
Recruiting
90 participants
Started: Feb 4, 2025 · Completed: Feb 1, 2028
1 condition
1 sponsor
90 locations
NCT06675929
A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH
PHASE2
Active, not recruiting
28 participants
Started: Feb 3, 2025 · Completed: Jan 12, 2026
2 conditions
1 sponsor
13 locations
NCT06769048
A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy
PHASE2
Recruiting
138 participants
Started: Jan 31, 2025 · Completed: Feb 26, 2027
1 condition
1 sponsor
44 locations
NCT06628622
A Study to Test Whether BI 1356225 Improves Impulsive Behavior in Men With Opioid Use Disorder Who Are Taking Buprenorphine
PHASE1
Recruiting
60 participants
Started: Jan 27, 2025 · Completed: Jun 3, 2026
1 condition
1 sponsor
6 locations
NCT06745297
A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated
PHASE1
Recruiting
142 participants
Started: Jan 23, 2025 · Completed: Aug 25, 2026
1 condition
1 sponsor
1 location
NCT06791122
A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia
NA
Active, not recruiting
262 participants
Started: Jan 23, 2025 · Completed: Aug 26, 2026
1 condition
1 sponsor
31 locations
NCT06722157
A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy
PHASE2
Active, not recruiting
188 participants
Started: Jan 6, 2025 · Completed: Oct 16, 2026
2 conditions
1 sponsor
47 locations
NCT06619509
A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine
PHASE2
Recruiting
90 participants
Started: Dec 30, 2024 · Completed: Dec 30, 2030
1 condition
1 sponsor
50 locations
NCT06636656
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
PHASE2
Recruiting
40 participants
Started: Dec 11, 2024 · Completed: Feb 29, 2028
1 condition
1 sponsor
52 locations
«
Previous
1
2
3
4
Next